Metyrapone

Metyrapone is a medicine used in a special test to help diagnose Cushing's syndrome. Cushing's syndrome is a condition where the body makes too much cortisol, a hormone that helps control stress. Metyrapone is used because it stops the body from making cortisol. Doctors use this test to see if the body is reacting normally to cortisol levels.

Brand names:Metopirone
Medication

What people taking Metyrapone report

Every report comes from a Lived member, sent anonymously.

Have you tried Metyrapone for Cushing Syndrome?

NameHow it went

About Metyrapone

What It's For

Metyrapone, sold in the US as Metopirone, is a prescription capsule that temporarily lowers the body's production of cortisol, the main stress hormone made by the adrenal glands. It has two quite different roles. Its FDA-approved use is diagnostic. Together with other tests, it helps doctors check for adrenal insufficiency in adults and children, a condition in which the adrenal glands do not make enough cortisol, often because the pituitary gland in the brain is not sending the right signal. In this role it is taken once, as part of a short test. Hormone specialists also prescribe it off label (for a use the FDA has not approved) to treat Cushing's syndrome, a condition caused by long-term excess cortisol. Surgery to remove the tumor driving the excess is usually the first choice. Metyrapone is one of the medicine options when surgery is not possible or has not fully worked.

How It Works

Metyrapone blocks an enzyme called 11-beta-hydroxylase, which the adrenal glands use for the final step in making cortisol. With that step blocked, cortisol levels fall and the hormone just before it in the production line, 11-deoxycortisol, builds up. The pituitary gland normally watches cortisol levels and releases a signaling hormone, ACTH (adrenocorticotropic hormone), when cortisol drops. That feedback is what makes metyrapone useful as a test. In a person whose pituitary and adrenal glands work normally, blocking cortisol triggers a surge of ACTH, and 11-deoxycortisol rises sharply. If that rise does not happen, the system is not responding as it should. In Cushing's syndrome, the same block simply limits how much cortisol the adrenal glands can produce. The build-up of precursor hormones explains some of its longer-term side effects: some have salt-retaining effects that can raise blood pressure, and the adrenal glands also make more androgens (male-type hormones).

Dosage & Administration

Metopirone comes as 250 mg capsules taken by mouth. For the diagnostic test, a single dose based on body weight is taken at midnight with milk, yogurt or a snack to reduce stomach upset. A blood sample is drawn early the next morning, usually around 7:30 to 8 a.m., to measure 11-deoxycortisol and sometimes ACTH. A rise in 11-deoxycortisol above about 70 micrograms per liter generally means the pituitary and adrenal system is working, though cutoffs depend on the lab. The test is often done at home, but people already suspected of having adrenal insufficiency are usually kept in the hospital overnight. Some medicines need to be paused beforehand (see Interactions & Warnings), so the care team should review everything you take well ahead of the test. For Cushing's syndrome, metyrapone is taken every day, with the total split into three or four doses spread through the day. The dose starts low and is adjusted every week or two at first, guided by cortisol measured in urine, blood or saliva. Some specialists deliberately block cortisol fully and add back a fixed dose of a steroid such as hydrocortisone, an approach called block and replace. Do not change the dose or the timing without talking to the prescriber.

Side Effects

Nausea, headache, dizziness, sleepiness and stomach discomfort are the most common effects. In a study of daily treatment for Cushing's syndrome, about 4 in 10 people had nausea and about a quarter had fatigue or headache, mostly in the first three months. Because dizziness and sleepiness can follow even a single test dose, do not drive or operate machinery until they have passed. The main risk is that cortisol falls too low, a state called adrenal insufficiency. Signs include nausea or vomiting, abdominal pain, unusual tiredness or weakness, and feeling dizzy or lightheaded from low blood pressure. These can be hard to tell apart from ordinary side effects, so contact the care team promptly if they appear, especially after a dose increase. In that study, about 1 in 8 people developed adrenal insufficiency while their dose was being adjusted; it resolved with a lower dose, a pause or short-term steroid treatment. Vomiting that stops you keeping fluids or medicines down, or fainting, can mean a developing adrenal crisis and needs emergency care. With longer use, the precursor hormones that build up can raise blood pressure, cause ankle swelling or lower potassium levels. In women, testosterone usually rises above the normal range, which can bring more facial or body hair or acne. Allergic rash and low blood counts have also been reported.

Interactions & Warnings

Metyrapone should not be used by people who already have known adrenal insufficiency, or who have had an allergic reaction to it. Before the diagnostic test, the care team usually confirms that the adrenal glands can still respond to stimulation, because the test can tip someone with very limited reserve into adrenal insufficiency. Thyroid that is overactive or underactive can also make the result look abnormal. Avoid acetaminophen, the pain reliever in Tylenol and many cold and flu products, while taking metyrapone. Metyrapone slows the body's clearance of acetaminophen, which raises the chance of its side effects. Several kinds of medicine can distort the test result: seizure medicines, some psychiatric medicines, hormone treatments, corticosteroids, thyroid medicines and cyproheptadine (an antihistamine). Where possible these are stopped beforehand, and if they cannot be, the doctor may decide the test is not the right choice. Metyrapone crosses the placenta and may lower the baby's own cortisol, and babies exposed during long-term treatment have occasionally been born with low cortisol. It has nonetheless been used in pregnancy when Cushing's syndrome needed treatment, so pregnancy calls for a specialist decision. It also passes into breast milk, and its effects on a breastfed baby are not known.

What to Expect

The diagnostic test is a one-night event. You take the capsule at midnight, may feel lightheaded or queasy, and have blood drawn the next morning. Results are interpreted alongside other hormone tests, so metyrapone alone rarely settles a diagnosis. After the blood draw, a doctor may give a dose of steroid to people at higher risk of adrenal insufficiency. For Cushing's syndrome, cortisol usually starts to fall within the first week or two. In a study of 49 adults, the median time to reach normal cortisol was about a month, and about half had normal urine cortisol after three months and kept it through nine months. Many others had a large drop without reaching normal. Quality of life improved over the same period, but the study had no comparison group. Expect frequent blood and urine tests early on, plus checks of blood pressure and potassium, then less often once the dose is stable. Metyrapone controls cortisol only while it is being taken; it does not remove the cause. How long someone stays on it depends on the cause of their Cushing's syndrome and what other treatment is planned, and the dose may need adjusting again later because cortisol levels can drift over time.

Questions to Ask Your Doctor

  1. 1.Am I having metyrapone as a one-time test or as ongoing treatment, and what will the result or the treatment tell us?
  2. 2.Which of my current medicines or supplements should I stop before the test, and for how long?
  3. 3.Should the test be done in the hospital overnight, given my symptoms and earlier results?
  4. 4.For Cushing's treatment, how will we know if cortisol is too low, and what should I do if I feel unwell between visits?
  5. 5.Why metyrapone for me rather than surgery, another cortisol-lowering medicine, or a combination?

Last reviewed • Oct 2026

Educational content, not medical advice.